Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment.
Pharmacy Department BC Children's Hospital and Children's & Women's Mental Health Programs BC Mental Health & Substance Use Services Vancouver, BC, Canada.
Dean
D
Elbe
Department of Anesthesiology, Pharmacology & Therapeutics University of British Columbia British Columbia Mental Health and Addictions Research Institute Vancouver, BC, Canada.
Alasdair M
AM
Barr
British Columbia Mental Health and Addictions Research Institute Department of Psychiatry University of British Columbia Vancouver, BC, Canada.
William G
WG
Honer
British Columbia Mental Health and Addictions Research Institute Department of Psychiatry University of British Columbia Vancouver, BC, Canada.
Ric M
RM
Procyshyn
D000374:Aggression / Q000187:drug effects; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D019958:Attention Deficit and Disruptive Behavior Disorders / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D000697:Central Nervous System Stimulants / Q000008:administration & dosage*; D002648:Child; D003692:Delayed-Action Preparations; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000008:administration & dosage*; D018967:Risperidone / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D003692:Delayed-Action Preparations; D008774:Methylphenidate; D018967:Risperidone